MENU
+Compare
RCKT
Stock ticker: NASDAQ
AS OF
Oct 8, 04:38 PM (EDT)
Price
$3.37
Change
+$0.23 (+7.32%)
Capitalization
338.82M

RCKT Rocket Pharmaceuticals Forecast, Technical & Fundamental Analysis

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company... Show more

Industry: #Biotechnology
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RCKT with price predictions
Oct 07, 2025

RCKT in +2.82% Uptrend, growing for three consecutive days on September 29, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RCKT advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on RCKT as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for RCKT crossed bullishly above the 50-day moving average on October 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

RCKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for RCKT turned negative on October 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

RCKT moved below its 50-day moving average on October 03, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCKT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RCKT entered a downward trend on October 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.957) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (342.085).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RCKT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RCKT is expected to report earnings to fall 21.84% to -48 cents per share on November 05

Rocket Pharmaceuticals RCKT Stock Earnings Reports
Q3'25
Est.
$-0.48
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.04
The last earnings report on August 07 showed earnings per share of -62 cents, missing the estimate of -56 cents. With 3.17M shares outstanding, the current market capitalization sits at 338.82M.
A.I. Advisor
published General Information

General Information

a provider of gene therapy services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9 Cedarbrook Drive
Phone
+1 609 659-8001
Employees
268
Web
https://www.rocketpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLDCF1.60N/A
+0.23%
Kenorland Minerals Ltd.
SPMYY10.74N/A
N/A
Spirent Communications Plc
WILLF35.87N/A
N/A
Demant AS
ATLPF18.33N/A
N/A
Atlas Copco AB
LBNKF0.21N/A
-0.26%
LithiumBank Resources Corp.

RCKT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-1.26%
SVRA - RCKT
61%
Loosely correlated
-0.87%
PRTA - RCKT
53%
Loosely correlated
+3.14%
AXON - RCKT
52%
Loosely correlated
-0.97%
VCYT - RCKT
47%
Loosely correlated
-3.97%
ARRY - RCKT
42%
Loosely correlated
-2.35%
More